These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 23241601
1. Switching between parathormone (PTH) assays: the impact on the diagnosis of renal osteodystrophy. Bekő G, Butz H, Berta K, Tislér A, Olajos F, Vásárhelyi B, Patócs A. Clin Chem Lab Med; 2013 Jun; 51(6):1251-6. PubMed ID: 23241601 [Abstract] [Full Text] [Related]
3. Higher parathyroid hormone (PTH) concentrations with the Architect PTH assay than with the Elecsys assay in hemodialysis patients, and a simple way to standardize these two methods. Monge M, Jean G, Bacri JL, Lemaitre V, Masy E, Joly D, Souberbielle JC. Clin Chem Lab Med; 2009 Jun; 47(3):362-6. PubMed ID: 19199835 [Abstract] [Full Text] [Related]
4. Lack of comparability of intact parathyroid hormone measurements among commercial assays for end-stage renal disease patients: implication for treatment decisions. Cantor T, Yang Z, Caraiani N, Ilamathi E. Clin Chem; 2006 Sep; 52(9):1771-6. PubMed ID: 16858070 [Abstract] [Full Text] [Related]
5. Influence of PTH assay methodology on differential diagnosis of renal bone disease. Reichel H, Esser A, Roth HJ, Schmidt-Gayk H. Nephrol Dial Transplant; 2003 Apr; 18(4):759-68. PubMed ID: 12637646 [Abstract] [Full Text] [Related]
6. [Diagnostic accuracy study comparing total alkaline phosphatase with intact parathyroid hormone 1-84 for the diagnosis of high turnover renal osteodystrophy in chronic renal failure on hemodialysis]. Rojas González AM, Opazo Valenzuela M, Muñoz Navarro S. Medwave; 2014 Sep 03; 14(8):e6014. PubMed ID: 25340338 [Abstract] [Full Text] [Related]
7. Influence of four different PTH methods on the classification of chronic kidney disease patients according to the new KDIGO guideline. Ten BE, Van Veen MC, Vervloet MG, Fischer JC, Koopman MG, Van Dam B. Clin Lab; 2012 Sep 03; 58(7-8):719-24. PubMed ID: 22997972 [Abstract] [Full Text] [Related]
8. Comparison of Two Parathyroid Hormone Assays in Hemodialysis Patients. Donati G, Cianciolo G, Capelli I, Baraldi O, Gambaretto C, Demelas V, Marchetti A, La Manna G. Artif Organs; 2016 Oct 03; 40(10):1013-1016. PubMed ID: 26670936 [Abstract] [Full Text] [Related]
9. Changes in total parathyroid hormone (PTH), PTH-(1-84) and large C-PTH fragments in different stages of chronic kidney disease. Herberth J, Fahrleitner-Pammer A, Obermayer-Pietsch B, Krisper P, Holzer H, Malluche HH, Dobnig H. Clin Nephrol; 2006 May 03; 65(5):328-34. PubMed ID: 16724653 [Abstract] [Full Text] [Related]
11. Inter-method variability in PTH measurement: implication for the care of CKD patients. Souberbielle JC, Boutten A, Carlier MC, Chevenne D, Coumaros G, Lawson-Body E, Massart C, Monge M, Myara J, Parent X, Plouvier E, Houillier P. Kidney Int; 2006 Jul 03; 70(2):345-50. PubMed ID: 16788691 [Abstract] [Full Text] [Related]
12. Specific measurement of PTH (1-84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry. Lehmann G, Stein G, Hüller M, Schemer R, Ramakrishnan K, Goodman WG. Kidney Int; 2005 Sep 03; 68(3):1206-14. PubMed ID: 16105052 [Abstract] [Full Text] [Related]
13. Comparison of Liaison N-tact PTH (Diasorin) and N-tact PTH SP IRMA (Diasorin) in hemodialyzed patients. Cavalier E, Delanaye P, Krzesinski JM, Chapelle JP. Clin Chem Lab Med; 2005 Sep 03; 43(8):890-1. PubMed ID: 16201903 [No Abstract] [Full Text] [Related]
14. [Tartrate-resistant acid phosphatase--TRAP 5b--as a novel marker of bone resorption in patients with irreversible renal failure treated with dialysis]. Nowak Z, Konieczna M, Wańkowicz Z. Pol Merkur Lekarski; 2004 Aug 03; 17(98):138-41. PubMed ID: 15603322 [Abstract] [Full Text] [Related]
15. Comparison of iPTH values in serum and plasma samples depending on the time and temperature in patients with chronic kidney disease. Bencova V, Maris K, Spustova V, Gazovic V, Straussova Z, Cernohorska B, Nemethova D. Bratisl Lek Listy; 2014 Aug 03; 115(7):439-41. PubMed ID: 25077368 [Abstract] [Full Text] [Related]
16. PTH 1-84 and PTH "7-84" in the noninvasive diagnosis of renal bone disease. Coen G, Bonucci E, Ballanti P, Balducci A, Calabria S, Nicolai GA, Fischer MS, Lifrieri F, Manni M, Morosetti M, Moscaritolo E, Sardella D. Am J Kidney Dis; 2002 Aug 03; 40(2):348-54. PubMed ID: 12148108 [Abstract] [Full Text] [Related]
17. Effects of Parathyroidectomy on Plasma iPTH and (1-84) PTH Levels in Patients with Stage 5 Chronic Kidney Disease. Huimin C, Ying C, Changying X, Xiaoming Z, Yan Z, Qingting W, Haoyang M, Lina Z, Ming Z, Guang Y, Xiaolin L, Purrunsing Y, Ningning W. Horm Metab Res; 2018 Oct 03; 50(10):761-767. PubMed ID: 30223287 [Abstract] [Full Text] [Related]
18. 7-84 parathyroid hormone fragments are proportionally increased with the severity of uremic hyperparathyroidism. Chang JM, Lin SP, Kuo HT, Tsai JC, Tomino Y, Lai YH, Chen HC. Clin Nephrol; 2005 May 03; 63(5):351-5. PubMed ID: 15909594 [Abstract] [Full Text] [Related]
19. Intraoperative measurement of intact parathyroid hormone in renal hyperparathyroidism by an inexpensive routine assay. Seehofer D, Rayes N, Ulrich F, Müller C, Lang M, Neuhaus P, Steinmüller T. Langenbecks Arch Surg; 2001 Nov 03; 386(6):440-3. PubMed ID: 11735018 [Abstract] [Full Text] [Related]
20. Predictive value of intact parathyroid hormone measurement during surgery for renal hyperparathyroidism. Seehofer D, Rayes N, Klupp J, Steinmüller T, Ulrich F, Müller C, Schindler R, Frei U, Neuhaus P. Langenbecks Arch Surg; 2005 Jun 03; 390(3):222-9. PubMed ID: 15726399 [Abstract] [Full Text] [Related] Page: [Next] [New Search]